Literature DB >> 11461969

Anandamide degradation and N-acylethanolamines level in wild-type and CB1 cannabinoid receptor knockout mice of different ages.

M Maccarrone1, M Attinà, M Bari, A Cartoni, C Ledent, A Finazzi-Agrò.   

Abstract

CD1 mice lacking the CB1 receptors (knockout, KO) were compared with wild-type littermates for their ability to degrade N-arachidonoylethanolamine (anandamide, AEA) through a membrane transporter (AMT) and a fatty acid amide hydrolase (FAAH). The regional distribution and age-dependence of AMT and FAAH activity were investigated. Anandamide membrane transporter and FAAH increased with age in knockout mice, whereas they showed minor changes in wild-type animals. Remarkably, they were higher in all brain areas of 6-month-old knockout versus wild-type mice, and even higher in 12-month-old animals. The molecular mass (approximately 67 kDa) and isoelectric point (approximately 7.6) of mouse brain FAAH were determined and the FAAH protein content was shown to parallel the enzyme activity. The kinetic constants of AMT and FAAH in the cortex of wild-type and knockout mice at different ages suggested that different amounts of the same proteins were expressed. The cortex and hippocampus of wild-type and knockout mice contained the following N-acylethanolamines: AEA (8% of total), 2-arachidonoylglycerol (5%), N-oleoylethanolamine (20%), N-palmitoylethanolamine (53%) and N-stearoylethanolamine (14%). These compounds were twice as abundant in the hippocampus as in the cortex. Minor differences were observed in AEA or 2-arachidonoylglycerol content in knockout versus wild-type mice, whereas the other compounds were lower in the hippocampus of knockout versus wild-type animals.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11461969     DOI: 10.1046/j.1471-4159.2001.00413.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  21 in total

Review 1.  Seeing through the smoke: Human and animal studies of cannabis use and endocannabinoid signalling in corticolimbic networks.

Authors:  Mason M Silveira; Jonathon C Arnold; Steven R Laviolette; Cecilia J Hillard; Marta Celorrio; María S Aymerich; Wendy K Adams
Journal:  Neurosci Biobehav Rev       Date:  2016-09-14       Impact factor: 8.989

2.  The fatty acid amide hydrolase C385A variant affects brain binding of the positron emission tomography tracer [11C]CURB.

Authors:  Isabelle Boileau; Rachel F Tyndale; Belinda Williams; Esmaeil Mansouri; Duncan J Westwood; Bernard Le Foll; Pablo M Rusjan; Romina Mizrahi; Vincenzo De Luca; Qian Zhou; Alan A Wilson; Sylvain Houle; Stephen J Kish; Junchao Tong
Journal:  J Cereb Blood Flow Metab       Date:  2015-06-03       Impact factor: 6.200

3.  Regulation of Fas receptor/Fas-associated protein with death domain apoptotic complex and associated signalling systems by cannabinoid receptors in the mouse brain.

Authors:  M Alvaro-Bartolomé; S Esteban; M S García-Gutiérrez; J Manzanares; O Valverde; J A García-Sevilla
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

Review 4.  [Dronabinol in geriatric pain and palliative care patients : A retrospective evaluation of statutory-health-insurance-covered outpatient medical treatment].

Authors:  Christoph Wendelmuth; Stefan Wirz; Misel Torontali; Anne Gastmeier; Knud Gastmeier
Journal:  Schmerz       Date:  2019-10       Impact factor: 1.107

Review 5.  The expanding field of cannabimimetic and related lipid mediators.

Authors:  Heather B Bradshaw; J Michael Walker
Journal:  Br J Pharmacol       Date:  2005-02       Impact factor: 8.739

6.  Enhanced Glutamatergic Synaptic Plasticity in the Hippocampal CA1 Field of Food-Restricted Rats: Involvement of CB1 Receptors.

Authors:  Giuseppe Talani; Valentina Licheri; Francesca Biggio; Valentina Locci; Maria Cristina Mostallino; Pietro Paolo Secci; Valentina Melis; Laura Dazzi; Gianfranca Carta; Sebastiano Banni; Giovanni Biggio; Enrico Sanna
Journal:  Neuropsychopharmacology       Date:  2015-09-10       Impact factor: 7.853

Review 7.  Cellular accumulation of anandamide: consensus and controversy.

Authors:  Cecilia J Hillard; Abbas Jarrahian
Journal:  Br J Pharmacol       Date:  2003-09-01       Impact factor: 8.739

8.  An optimized GC-MS method detects nanomolar amounts of anandamide in mouse brain.

Authors:  Giulio G Muccioli; Nephi Stella
Journal:  Anal Biochem       Date:  2007-09-29       Impact factor: 3.365

9.  Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission.

Authors:  Paolo Gubellini; Barbara Picconi; Monica Bari; Natalia Battista; Paolo Calabresi; Diego Centonze; Giorgio Bernardi; Alessandro Finazzi-Agrò; Mauro Maccarrone
Journal:  J Neurosci       Date:  2002-08-15       Impact factor: 6.167

Review 10.  The endocannabinoid system in normal and pathological brain ageing.

Authors:  Andras Bilkei-Gorzo
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-12-05       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.